Literature DB >> 30755145

The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.

M Yuan1,2,3,4, Y Tan1,2,3,4, Y Wang1,2,3,4, S X Wang1,2,3,4, F Yu1,2,3,4,5, M H Zhao1,2,3,4,6.   

Abstract

Our study aims to evaluate the endothelial cell-podocyte crosstalk in proliferative lupus nephritis (LN). The semi-quantification scores of glomerular endothelial cell injury and the foot process width (FPW) were processed in 110 proliferative LN patients. Podocytes were stimulated with LN-derived IgG. Glomerular endothelial cells were treated with podocyte-conditioned medium (PCM), and then podocytes were incubated with endothelial cell-conditioned medium (ECM). The levels of vascular endothelial growth factor-A (VEGF-A) in PCM and endothelin-1 in ECM were analyzed, and the injury of podocyte and glomerular endothelial cells were further evaluated. The pathological score of glomerular endothelial cell injury was correlated with FPW in LN complicated with thrombotic microangiopathy. In vitro study showed the following: 1. Stimulation of podocytes by IgG from LN led to decline in the expression of nephrin with cytoskeleton rearrangement, and reduction of VEGF-A levels. 2. Exposure of glomerular endothelial cells to PCM incubated with LN-derived IgG (PCM-LN) induced more endothelin-1 secretion and disruption of intercellular tight junction. 3. Exposure of podocytes to ECM stimulated with PCM-LN could induce cytoskeleton redistribution with decrease of nephrin. In conclusion, the pathological glomerular endothelial cell lesions were associated with FPW and the VEGF-endothelin-1 system might play a critical role in the endothelial cell-podocyte crosstalk in LN.

Entities:  

Keywords:  Systemic lupus erythematosus; crosstalk; glomerular endothelial cell; lupus nephritis; podocyte

Mesh:

Substances:

Year:  2019        PMID: 30755145     DOI: 10.1177/0961203319828509

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  2 in total

1.  Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.

Authors:  Shuiqin Cheng; Li Huang; Wenjing Fan; Dandan Liang; Xiaodong Zhu; Song Jiang; Yongchun Ge
Journal:  Int Urol Nephrol       Date:  2022-02-08       Impact factor: 2.266

Review 2.  Vascular Endothelial Growth Factor Biology and Its Potential as a Therapeutic Target in Rheumatic Diseases.

Authors:  Thi Hong Van Le; Sang-Mo Kwon
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.